Systematic analysis and comparison of O-glycosylation of five recombinant spike proteins in β-coronaviruses

Anal Chim Acta. 2022 Oct 16:1230:340394. doi: 10.1016/j.aca.2022.340394. Epub 2022 Sep 16.

Abstract

β-coronaviruses (β-CoVs), representative with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), depend on their highly glycosylated spike proteins to mediate cell entry and membrane fusion. Compared with the extensively identified N-glycosylation, less is known about O-glycosylation of β-CoVs S proteins, let alone its biological functions. Herein we comprehensively characterized O-glycosylation of five recombinant β-CoVs S1 subunits and revealed the macro- and micro-heterogeneity nature of site-specific O-glycosylation. We also uncovered the O-glycosylation differences between SARS-CoV-2 and its natural D614G mutant on functional domains. This work describes the systematic O-glycosylation analysis of β-CoVs S1 proteins and will help to guide the related vaccines and antiviral drugs development.

Keywords: Characterization; O-Glycosylation; Sialylation; Spike proteins; β-coronavirus.

MeSH terms

  • Antiviral Agents
  • COVID-19*
  • Fibronectins
  • Glycosylation
  • Humans
  • SARS-CoV-2 / genetics
  • Spike Glycoprotein, Coronavirus* / genetics

Substances

  • Antiviral Agents
  • Fibronectins
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2